Sep. 18, 2021

daridorexant

dual orexin receptor GPCR antagonist Ph. III efficacy for insomnia, oral 25-50 mg from optimization of prior clinical candidate ChemMedChem., Oct. 28, 2020 Idorsia Pharmaceuticals, Allschwil, CH

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in